Global Therapeutic Nuclear Medicines Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Summary
Market Overview
The global Therapeutic Nuclear Medicines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 17.2% in the forecast period of 2020 to 2025 and will expected to reach USD 2348.8 million by 2025, from USD 1243.8 million in 2019.
The Therapeutic Nuclear Medicines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Therapeutic Nuclear Medicines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Therapeutic Nuclear Medicines market has been segmented into Radium-223, Lutetium-177, Iodine-131, Other, etc.
By Application, Therapeutic Nuclear Medicines has been segmented into Thyroid, Bone Metastasis, Lymphoma, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Therapeutic Nuclear Medicines market presented in the report. This section sheds light on the sales growth of different regional and country-level Therapeutic Nuclear Medicines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Therapeutic Nuclear Medicines market.
The report offers in-depth assessment of the growth and other aspects of the Therapeutic Nuclear Medicines market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Therapeutic Nuclear Medicines markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Therapeutic Nuclear Medicines Market Share Analysis
Therapeutic Nuclear Medicines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Therapeutic Nuclear Medicines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Therapeutic Nuclear Medicines sales, revenue and market share for each player covered in this report.
The major players covered in Therapeutic Nuclear Medicines are: Bayer, Lantheus, Dongcheng, Novartis AG, Jubilant DraxImage, China Isotope & Radiation, Progenics Pharmaceuticals, Curium Pharmaceuticals, Q BioMed, Spectrum Pharmaceuticals, International Isotopes, etc. Among other players domestic and global, Therapeutic Nuclear Medicines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Nuclear Medicines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Therapeutic Nuclear Medicines, with price, sales, revenue and global market share of Therapeutic Nuclear Medicines in 2018 and 2019.
Chapter 3, the Therapeutic Nuclear Medicines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Nuclear Medicines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Therapeutic Nuclear Medicines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Therapeutic Nuclear Medicines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Therapeutic Nuclear Medicines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Therapeutic Nuclear Medicines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Therapeutic Nuclear Medicines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Overview of Global Therapeutic Nuclear Medicines Market
1.4.1 Global Therapeutic Nuclear Medicines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lantheus
2.2.1 Lantheus Details
2.2.2 Lantheus Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lantheus SWOT Analysis
2.2.4 Lantheus Product and Services
2.2.5 Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Dongcheng
2.3.1 Dongcheng Details
2.3.2 Dongcheng Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Dongcheng SWOT Analysis
2.3.4 Dongcheng Product and Services
2.3.5 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis AG SWOT Analysis
2.4.4 Novartis AG Product and Services
2.4.5 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Jubilant DraxImage
2.5.1 Jubilant DraxImage Details
2.5.2 Jubilant DraxImage Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Jubilant DraxImage SWOT Analysis
2.5.4 Jubilant DraxImage Product and Services
2.5.5 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 China Isotope & Radiation
2.6.1 China Isotope & Radiation Details
2.6.2 China Isotope & Radiation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 China Isotope & Radiation SWOT Analysis
2.6.4 China Isotope & Radiation Product and Services
2.6.5 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Progenics Pharmaceuticals
2.7.1 Progenics Pharmaceuticals Details
2.7.2 Progenics Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Progenics Pharmaceuticals SWOT Analysis
2.7.4 Progenics Pharmaceuticals Product and Services
2.7.5 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Curium Pharmaceuticals
2.8.1 Curium Pharmaceuticals Details
2.8.2 Curium Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Curium Pharmaceuticals SWOT Analysis
2.8.4 Curium Pharmaceuticals Product and Services
2.8.5 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Q BioMed
2.9.1 Q BioMed Details
2.9.2 Q BioMed Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Q BioMed SWOT Analysis
2.9.4 Q BioMed Product and Services
2.9.5 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Spectrum Pharmaceuticals
2.10.1 Spectrum Pharmaceuticals Details
2.10.2 Spectrum Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Spectrum Pharmaceuticals SWOT Analysis
2.10.4 Spectrum Pharmaceuticals Product and Services
2.10.5 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 International Isotopes
2.11.1 International Isotopes Details
2.11.2 International Isotopes Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 International Isotopes SWOT Analysis
2.11.4 International Isotopes Product and Services
2.11.5 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Therapeutic Nuclear Medicines Manufacturer Market Share in 2019
3.3.2 Top 6 Therapeutic Nuclear Medicines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Regions
4.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Regions (2015-2020)
4.2 North America Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
4.3 Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
4.5 South America Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
5.1.1 North America Therapeutic Nuclear Medicines Sales and Market Share by Country (2015-2020)
5.1.2 North America Therapeutic Nuclear Medicines Revenue and Market Share by Country (2015-2020)
5.2 United States Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
5.3 Canada Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
5.4 Mexico Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
6.1.1 Europe Therapeutic Nuclear Medicines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Therapeutic Nuclear Medicines Revenue and Market Share by Country (2015-2020)
6.2 Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
6.3 UK Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
6.4 France Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
6.5 Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
6.6 Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Therapeutic Nuclear Medicines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Market Share by Regions (2015-2020)
7.2 China Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
7.3 Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
7.4 Korea Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
7.5 India Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
7.7 Australia Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
8.1.1 South America Therapeutic Nuclear Medicines Sales and Market Share by Country (2015-2020)
8.1.2 South America Therapeutic Nuclear Medicines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
8.3 Argentina Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Therapeutic Nuclear Medicines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Therapeutic Nuclear Medicines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
9.3 Turkey Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
9.4 Egypt Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
9.5 South Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Type (2015-2020)
10.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2015-2020)
10.3 Global Therapeutic Nuclear Medicines Price by Type (2015-2020)
11 Global Therapeutic Nuclear Medicines Market Segment by Application
11.1 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2015-2020)
11.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2015-2020)
11.3 Global Therapeutic Nuclear Medicines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate (2021-2025)
12.2 Therapeutic Nuclear Medicines Market Forecast by Regions (2021-2025)
12.2.1 North America Therapeutic Nuclear Medicines Market Forecast (2021-2025)
12.2.2 Europe Therapeutic Nuclear Medicines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Therapeutic Nuclear Medicines Market Forecast (2021-2025)
12.2.4 South America Therapeutic Nuclear Medicines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Therapeutic Nuclear Medicines Market Forecast (2021-2025)
12.3 Therapeutic Nuclear Medicines Market Forecast by Type (2021-2025)
12.3.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2021-2025)
12.3.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Type (2021-2025)
12.4 Therapeutic Nuclear Medicines Market Forecast by Application (2021-2025)
12.4.1 Global Therapeutic Nuclear Medicines Sales Forecast by Application (2021-2025)
12.4.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Tables and Figures
List of Tables
Table 1. Global Therapeutic Nuclear Medicines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Therapeutic Nuclear Medicines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Therapeutic Nuclear Medicines Major Business
Table 9. Bayer Therapeutic Nuclear Medicines Total Revenue (USD Million) (2017-2018)
Table 10. Bayer SWOT Analysis
Table 11. Bayer Therapeutic Nuclear Medicines Product and Services
Table 12. Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Lantheus Basic Information, Manufacturing Base and Competitors
Table 14. Lantheus Therapeutic Nuclear Medicines Major Business
Table 15. Lantheus Therapeutic Nuclear Medicines Total Revenue (USD Million) (2017-2018)
Table 16. Lantheus SWOT Analysis
Table 17. Lantheus Therapeutic Nuclear Medicines Product and Services
Table 18. Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 20. Dongcheng Therapeutic Nuclear Medicines Major Business
Table 21. Dongcheng Therapeutic Nuclear Medicines Total Revenue (USD Million) (2017-2018)
Table 22. Dongcheng SWOT Analysis
Table 23. Dongcheng Therapeutic Nuclear Medicines Product and Services
Table 24. Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 26. Novartis AG Therapeutic Nuclear Medicines Major Business
Table 27. Novartis AG Therapeutic Nuclear Medicines Total Revenue (USD Million) (2017-2018)
Table 28. Novartis AG SWOT Analysis
Table 29. Novartis AG Therapeutic Nuclear Medicines Product and Services
Table 30. Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Jubilant DraxImage Basic Information, Manufacturing Base and Competitors
Table 32. Jubilant DraxImage Therapeutic Nuclear Medicines Major Business
Table 33. Jubilant DraxImage Therapeutic Nuclear Medicines Total Revenue (USD Million) (2017-2018)
Table 34. Jubilant DraxImage SWOT Analysis
Table 35. Jubilant DraxImage Therapeutic Nuclear Medicines Product and Services
Table 36. Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 38. China Isotope & Radiation Therapeutic Nuclear Medicines Major Business
Table 39. China Isotope & Radiation Therapeutic Nuclear Medicines Total Revenue (USD Million) (2017-2018)
Table 40. China Isotope & Radiation SWOT Analysis
Table 41. China Isotope & Radiation Therapeutic Nuclear Medicines Product and Services
Table 42. China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Major Business
Table 45. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Total Revenue (USD Million) (2017-2018)
Table 46. Progenics Pharmaceuticals SWOT Analysis
Table 47. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
Table 48. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. Curium Pharmaceuticals Therapeutic Nuclear Medicines Major Business
Table 51. Curium Pharmaceuticals Therapeutic Nuclear Medicines Total Revenue (USD Million) (2017-2018)
Table 52. Curium Pharmaceuticals SWOT Analysis
Table 53. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
Table 54. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Q BioMed Basic Information, Manufacturing Base and Competitors
Table 56. Q BioMed Therapeutic Nuclear Medicines Major Business
Table 57. Q BioMed Therapeutic Nuclear Medicines Total Revenue (USD Million) (2017-2018)
Table 58. Q BioMed SWOT Analysis
Table 59. Q BioMed Therapeutic Nuclear Medicines Product and Services
Table 60. Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Major Business
Table 63. Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Total Revenue (USD Million) (2017-2018)
Table 64. Spectrum Pharmaceuticals SWOT Analysis
Table 65. Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
Table 66. Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. International Isotopes Basic Information, Manufacturing Base and Competitors
Table 68. International Isotopes Therapeutic Nuclear Medicines Major Business
Table 69. International Isotopes Therapeutic Nuclear Medicines Total Revenue (USD Million) (2017-2018)
Table 70. International Isotopes SWOT Analysis
Table 71. International Isotopes Therapeutic Nuclear Medicines Product and Services
Table 72. International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Therapeutic Nuclear Medicines Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Therapeutic Nuclear Medicines Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Therapeutic Nuclear Medicines Sales by Regions (2015-2020) (K Units)
Table 76. Global Therapeutic Nuclear Medicines Sales Market Share by Regions (2015-2020)
Table 77. Global Therapeutic Nuclear Medicines Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Therapeutic Nuclear Medicines Sales by Countries (2015-2020) (K Units)
Table 79. North America Therapeutic Nuclear Medicines Sales Market Share by Countries (2015-2020)
Table 80. North America Therapeutic Nuclear Medicines Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Therapeutic Nuclear Medicines Revenue Market Share by Countries (2015-2020)
Table 82. Europe Therapeutic Nuclear Medicines Sales by Countries (2015-2020) (K Units)
Table 83. Europe Therapeutic Nuclear Medicines Sales Market Share by Countries (2015-2020)
Table 84. Europe Therapeutic Nuclear Medicines Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Therapeutic Nuclear Medicines Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Therapeutic Nuclear Medicines Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Therapeutic Nuclear Medicines Sales by Countries (2015-2020) (K Units)
Table 89. South America Therapeutic Nuclear Medicines Sales Market Share by Countries (2015-2020)
Table 90. South America Therapeutic Nuclear Medicines Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Therapeutic Nuclear Medicines Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Therapeutic Nuclear Medicines Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Therapeutic Nuclear Medicines Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries (2015-2020)
Table 96. Global Therapeutic Nuclear Medicines Sales by Type (2015-2020) (K Units)
Table 97. Global Therapeutic Nuclear Medicines Sales Share by Type (2015-2020)
Table 98. Global Therapeutic Nuclear Medicines Revenue by Type (2015-2020) (USD Million)
Table 99. Global Therapeutic Nuclear Medicines Revenue Share by Type (2015-2020)
Table 100. Global Therapeutic Nuclear Medicines Sales by Application (2015-2020) (K Units)
Table 101. Global Therapeutic Nuclear Medicines Sales Share by Application (2015-2020)
Table 102. Global Therapeutic Nuclear Medicines Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Therapeutic Nuclear Medicines Market Share Forecast by Regions (2021-2025)
Table 104. Global Therapeutic Nuclear Medicines Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Therapeutic Nuclear Medicines Market Share Forecast by Type (2021-2025)
Table 106. Global Therapeutic Nuclear Medicines Sales Forecast by Application (2021-2025)
Table 107. Global Therapeutic Nuclear Medicines Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Therapeutic Nuclear Medicines Picture
Figure 2. Global Sales Market Share of Therapeutic Nuclear Medicines by Type in 2019
Figure 3. Radium-223 Picture
Figure 4. Lutetium-177 Picture
Figure 5. Iodine-131 Picture
Figure 6. Other Picture
Figure 7. Therapeutic Nuclear Medicines Sales Market Share by Application in 2018
Figure 8. Thyroid Picture
Figure 9. Bone Metastasis Picture
Figure 10. Lymphoma Picture
Figure 11. Other Picture
Figure 12. Global Therapeutic Nuclear Medicines Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturer in 2019
Figure 33. Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Therapeutic Nuclear Medicines Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Therapeutic Nuclear Medicines Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Therapeutic Nuclear Medicines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Therapeutic Nuclear Medicines Revenue Market Share by Regions (2015-2020)
Figure 40. Global Therapeutic Nuclear Medicines Revenue Market Share by Regions in 2018
Figure 41. North America Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
Figure 42. Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
Figure 44. South America Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020)
Figure 46. North America Therapeutic Nuclear Medicines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Therapeutic Nuclear Medicines Sales Market Share by Countries (2015-2020)
Figure 48. North America Therapeutic Nuclear Medicines Sales Market Share by Countries in 2018
Figure 49. North America Therapeutic Nuclear Medicines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2018
Figure 51. United States Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2019
Figure 57. Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Therapeutic Nuclear Medicines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share by Regions 2019
Figure 65. China Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Therapeutic Nuclear Medicines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Therapeutic Nuclear Medicines Sales Market Share by Countries in 2019
Figure 72. South America Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2019
Figure 73. Brazil Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Therapeutic Nuclear Medicines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Therapeutic Nuclear Medicines Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Therapeutic Nuclear Medicines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Therapeutic Nuclear Medicines Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Therapeutic Nuclear Medicines Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Therapeutic Nuclear Medicines Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Therapeutic Nuclear Medicines Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Therapeutic Nuclear Medicines Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets